Description Semaglutide is a long-acting GLP-1 receptor agonist, structurally modified to resist enzymatic degradation and allow for prolonged activity in the body. It mimics the action of endogenous glucagon-like peptide-1, a hormone that plays a key role in glucose-dependent insulin secretion, inhibition of glucagon release, and delayed gastric emptying. Research has shown that semaglutide significantly improves glycemic control, reduces…
Description Semax is a synthetic peptide analog of the ACTH (4–10) fragment, modified to increase stability and enhance its neurotropic activity. It has been extensively studied in neuropharmacological research for its nootropic, neuroprotective, and anti-inflammatory properties, particularly in models of cerebral ischemia, cognitive impairment, and neurodegenerative conditions. Semax is believed to work through modulation of the brain-derived neurotrophic factor…
